Kamran Bakhtiari

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.

A first-in-human study evaluating safety, PK, and PD of a novel universal anticoagulant reversal agent, OKL-1111.

Journal: Blood vessels, thrombosis & hemostasis

Published: July 07, 2025

Reversal of factor XI targeting anticoagulants: an in vitro evaluation.

Reversal of factor XI targeting anticoagulants: an in vitro evaluation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 30, 2023

Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism.

Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolism.

Journal: Journal of critical care

Published: May 15, 2023

OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants.

OKL-1111, A modified cyclodextrin as a potential universal reversal agent for anticoagulants.

Journal: Thrombosis research

Published: February 13, 2023

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.

Nanobodies against factor XI apple 3 domain inhibit binding of factor IX and reveal a novel binding site for high molecular weight kininogen.

Journal: Journal of thrombosis and haemostasis : JTH

Published: May 20, 2022

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex.

Iron-Driven Alterations on Red Blood Cell-Derived Microvesicles Amplify Coagulation during Hemolysis via the Intrinsic Tenase Complex.

Journal: Thrombosis and haemostasis

Published: May 03, 2021

In vitro evaluation of factor IX as novel treatment for factor XI deficiency.

In vitro evaluation of factor IX as novel treatment for factor XI deficiency.

Journal: Blood

Published: May 26, 2019

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI.

Chemical Footprinting Reveals Conformational Changes Following Activation of Factor XI.

Journal: Thrombosis and haemostasis

Published: January 30, 2018

Zeolite Nanoparticles for Selective Sorption of Plasma Proteins.

Zeolite Nanoparticles for Selective Sorption of Plasma Proteins.

Journal: Scientific reports

Published: July 23, 2015

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function.

A novel mutation in the F5 gene (factor V Amsterdam) associated with bleeding independent of factor V procoagulant function.

Journal: Blood

Published: January 31, 2015

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Effect of Puumala hantavirus infection on human umbilical vein endothelial cell hemostatic function: platelet interactions, increased tissue factor expression and fibrinolysis regulator release.

Journal: Frontiers in microbiology

Published: January 15, 2015

Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries.

Abnormal hemostatic parameters in patients with myocardial infarction but angiographically normal coronary arteries.

Journal: International journal of cardiology

Published: March 30, 2014

Showing 1-12 of 18

Last Updated: 09/26/2026